Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma Sales Reps May Get Overtime After Appeals Court Defers To Department Of Labor

This article was originally published in The Pink Sheet Daily

Executive Summary

Novartis plaintiffs seek at least $100 million in overtime; Second Circuit's ruling may impact similar suits against more than a dozen other companies.

You may also be interested in...

Novartis Settles Sales Rep Overtime Suit Rather Than Await Supreme Court Ruling

Novartis agrees to pay $99 million to resolve a class action on behalf of 7,700 current and former sales representatives. The company changed the duties of its reps and cut their work hours after the suit was filed.

Is A Pharma Sales Rep A Salesman? Supreme Court To Make Final Call

Court to decide whether sales reps qualify for overtime pay in case involving former GlaxoSmithKline reps; it is the third pharma case this term.

GSK Sales Reps Are Latest To Urge Supreme Court To Review Overtime Pay

The court is being asked for the second time to address whether pharmaceutical sales reps are exempt from receiving overtime pay under the Fair Labor Standards Act.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts